Azienda Usl 7; Dept. Oncologico

Poggibonsi, Tuscany 53036

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Triple Negative Breast Cancer

Studies at this site

• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early
• A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer — Completed